The peptide known as BPC‑157 (pentadecapeptide BPC-157) has garnered increasing attention across research domains ...

Researchers at Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) have developed an innovative microscopy ...

The Michigan House has passed bipartisan legislation to ban student cell phone use during classroom instruction across all ...

"Kymera enters 2026 from a position of exceptional strength, driven by significant progress in the clinic and the consistent execution of our strategy,” said Nello Mainolfi, PhD ...

Summit Therapeutics has submitted a Biologics License Application to the FDA for ivonescimab, a first-in-class bispecific ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

Preliminary Unaudited Fourth Quarter and Full Year 2025 Results Core revenue in the fourth quarter is expected to be between $6.6 million and $6.7 million. Core revenue for the full year is expected ...

CBSE Class 12 practical examinations for the 2026 board exams are being scheduled in many schools during the second half of ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...